Stacy W Gray

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Attitudes of patients with cancer about personalized medicine and somatic genetic testing
    Stacy W Gray
    Center for Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, LW 633, Boston, MA 02215, USA
    J Oncol Pract 8:329-35, 2 p following 335. 2012
  2. pmc Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications
    Stacy W Gray
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 115:1424-34. 2009
  3. pmc Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer
    Stacy W Gray
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:1303-11. 2009
  4. doi request reprint The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations
    S W Gray
    Population Sciences, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Clin Genet 81:29-37. 2012
  5. doi request reprint Class, race, ethnicity and information needs in post-treatment cancer patients
    Ezequiel M Galarce
    Harvard School of Public Health, Boston, USA
    Patient Educ Couns 85:432-9. 2011
  6. pmc Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey
    Rebekah H Nagler
    Center for Community Based Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Patient Educ Couns 81:S54-62. 2010
  7. pmc Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas
    Lynette M Sholl
    Department of Pathology Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Thorac Oncol 8:322-8. 2013
  8. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
  9. pmc Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity
    Selwyn O Rogers
    Department of Surgery and Center for Surgery and Public Health, Brigham and Women s Hospital, Boston, MA, USA
    Ann Surg Oncol 17:1581-8. 2010

Detail Information

Publications9

  1. pmc Attitudes of patients with cancer about personalized medicine and somatic genetic testing
    Stacy W Gray
    Center for Population Sciences, Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Ave, LW 633, Boston, MA 02215, USA
    J Oncol Pract 8:329-35, 2 p following 335. 2012
    ..Dramatic advances in genomic technology stand to revolutionize cancer care; however, little is known about patients' understanding and acceptance of personalized medicine and widespread genetic testing (GT)...
  2. pmc Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications
    Stacy W Gray
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 115:1424-34. 2009
    ....
  3. pmc Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer
    Stacy W Gray
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 18:1303-11. 2009
    ..Direct-to-consumer (DTC) BRCA testing may expand access to genetic testing and enhance cancer prevention efforts. It is not known, however, if current DTC websites provide adequate risk information for informed medical decision making...
  4. doi request reprint The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations
    S W Gray
    Population Sciences, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Clin Genet 81:29-37. 2012
    ..Exposing women to the potential risks of DTC BRCA testing altered their beliefs, preferences, and intentions. Risk messages appear to be salient to women irrespective of their chance of having a BRCA mutation...
  5. doi request reprint Class, race, ethnicity and information needs in post-treatment cancer patients
    Ezequiel M Galarce
    Harvard School of Public Health, Boston, USA
    Patient Educ Couns 85:432-9. 2011
    ..The goal of this study was to develop a taxonomy of topics for which post-treatment cancer patients sought information, and to explore HISB patterns by sociodemographic factors and cancer type...
  6. pmc Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey
    Rebekah H Nagler
    Center for Community Based Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Patient Educ Couns 81:S54-62. 2010
    ..Yet little is known about whether patients with different types of cancer vary in their information needs and seeking behaviors. This study used population-based data to address this question...
  7. pmc Combined use of ALK immunohistochemistry and FISH for optimal detection of ALK-rearranged lung adenocarcinomas
    Lynette M Sholl
    Department of Pathology Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Thorac Oncol 8:322-8. 2013
    ..Immunohistochemistry (IHC) for ALK protein overexpression is a promising screening modality, with reports of newer antibodies showing excellent sensitivity and specificity for ALK-rearranged lung ACA...
  8. pmc Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    JAMA 307:1593-601. 2012
    ..However, longer survival was not observed in the subgroup of patients aged 65 years or older...
  9. pmc Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity
    Selwyn O Rogers
    Department of Surgery and Center for Surgery and Public Health, Brigham and Women s Hospital, Boston, MA, USA
    Ann Surg Oncol 17:1581-8. 2010
    ..We surveyed surgeons to understand how their recommendations for lobectomy were influenced by age, the presence and severity of smoking-related lung disease, or by characteristics of the surgeons and their practices...